ziprasidone
Commercial- Indications
- Mental disorders
Company intelligence / Profile preview
九典制药
长沙 Changsha / 浏阳 Liuyang / 长沙高新区 Lugu High-tech Zone / 长沙望城区 Wangcheng District, 湖南省 Hunan Province, 中国 Chinahnjiudian.com ↗
- Ownership
- Private
- Employees
- ~2100
- Development stage
- Commercial
01
Overview
九典制药是一家集研发、生产、销售和CXO服务于一体的现代化上市医药企业，专注于化学仿制药、中成药、原料药及外用贴剂等领域。公司在经皮给药领域处于国内领先地位，拥有多个自主研发的黄金品种，2023年营收近27亿元人民币，净利润3.7亿元[2]。
- Therapeutic areas
- Metabolic DisordersPulmonologyCardiovascularNeurologyInfectious Diseases
- Modalities
- Small molecules (化学药物)Herbal medicines (中药)Excipients (辅料)Topical/transdermal formulations
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on 九典制药.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 九典制药.